Your browser doesn't support javascript.
loading
Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data.
Tomida, Ryotaro; Miyake, Makito; Minato, Ryoei; Sawada, Yuichiro; Matsumura, Masafumi; Iida, Kota; Hori, Shunta; Fukui, Shinji; Ohyama, Chikara; Miyake, Hideaki; Hongo, Fumiya; Taoka, Rikiya; Kobayashi, Takashi; Kojima, Takahiro; Matsui, Yoshiyuki; Nishiyama, Naotaka; Kitamura, Hiroshi; Nishiyama, Hiroyuki; Fujimoto, Kiyohide; Hashine, Katsuyoshi.
Afiliação
  • Tomida R; Urology, National Hospital Organization Shikoku Cancer Center, Ehime, Metsuyama, Japan.
  • Miyake M; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan. makitomiyake@yahoo.co.jp.
  • Minato R; Urology, National Hospital Organization Shikoku Cancer Center, Ehime, Metsuyama, Japan.
  • Sawada Y; Urology, National Hospital Organization Shikoku Cancer Center, Ehime, Metsuyama, Japan.
  • Matsumura M; Urology, National Hospital Organization Shikoku Cancer Center, Ehime, Metsuyama, Japan.
  • Iida K; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.
  • Hori S; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.
  • Fukui S; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.
  • Ohyama C; Department of Urology, Hirosaki University School of Medicine, Hirosaki, Japan.
  • Miyake H; Department of Urology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan.
  • Hongo F; Department of Urology, Kyoto Prefectural University of Medicine, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, 602-8566, Japan.
  • Taoka R; Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
  • Kobayashi T; Department of Urology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Kojima T; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Matsui Y; Department of Urology, National Cancer Center Hospital, Tokyo, Japan.
  • Nishiyama N; Department of Urology, Faculty of Medicine, University of Toyama, Toyama, Toyama, Japan.
  • Kitamura H; Department of Urology, Faculty of Medicine, University of Toyama, Toyama, Toyama, Japan.
  • Nishiyama H; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
  • Fujimoto K; Department of Urology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8522, Japan.
  • Hashine K; Urology, National Hospital Organization Shikoku Cancer Center, Ehime, Metsuyama, Japan.
Int J Clin Oncol ; 27(5): 958-968, 2022 May.
Article em En | MEDLINE | ID: mdl-35142962
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma in Situ Tipo de estudo: Observational_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma in Situ Tipo de estudo: Observational_studies / Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article